Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
Neoplasia (New York, N.Y.)|October 28, 2008
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancerSooryanarayana Varambally, Bharathi Laxman, Rohit Mehra, et al.
Neoplasia (New York, N.Y.)|August 28, 2016
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate CancerSudhanshu Shukla, Xiang Zhang, Yashar S Niknafs, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2021
Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy responseYuping Zhang, Sathiya P Narayanan, Rahul Mannan, et al.
Neoplasia (New York, N.Y.)|February 3, 2025
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastomaSeema Chugh, Jean C Tien, Jennifer Hon, et al.
Molecular Cancer Research : MCR|July 18, 2014
The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancerRohit Malik, Lalit Patel, John R Prensner, et al.
Nature|August 3, 2007
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancerScott A Tomlins, Bharathi Laxman, Saravana M Dhanasekaran, et al.
Histopathology|December 25, 2019
Clinicopathological characterisation of renal cell carcinoma in young adults: a contemporary update and review of literatureEman Abdulfatah, John M Kennedy, Khaled Hafez, et al.
Nature Genetics|January 20, 2015
The landscape of long noncoding RNAs in the human transcriptomeMatthew K Iyer, Yashar S Niknafs, Rohit Malik, et al.
Genome Research|July 5, 2011
Deep sequencing reveals distinct patterns of DNA methylation in prostate cancerJung H Kim, Saravana M Dhanasekaran, John R Prensner, et al.
Pageof 12